Domzalski David
CEO at Foamix Pharmaceuticals Ltd.
- Sold, on record
- $114k
- Dollars the filings state
- Form 4 sales
- 12
- Latest Jul 1, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Foamix Pharmaceuticals Ltd.UnusualAug 8, 2018 2018
Sold 8,238 shares at $5.68 ($47k)
Domzalski David, CEO
Sold 5.1% of holdings ($923k position)154,243 shares left24.6x usual sizeFiling
- 2 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedSep 4, 2018 +27 days
Sold 67 shares at $5.67 ($380)
Domzalski David, CEO
Sold 0% of holdings ($875k position)154,176 shares left0.1x usual sizeFiling
- 3 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedOct 1, 2018 +27 days
Sold 601 shares at $5.81 ($3k)
Domzalski David, CEO
Sold 0.4% of holdings ($896k position)153,575 shares left1.8x usual sizeFiling
- 4 Form 4 sale Foamix Pharmaceuticals Ltd.UnusualNov 8, 2018 +38 days
Sold 2,062 shares at $4.58 ($9k)
Domzalski David, CEO
Sold 1.3% of holdings ($703k position)151,513 shares left3.4x usual sizeFiling
- 5 Form 4 sale Foamix Pharmaceuticals Ltd.UnusualNov 19, 2018 +11 days
Sold 5,036 shares at $3.90 ($20k)
Domzalski David, CEO
Sold 3.3% of holdings ($591k position)146,477 shares left8.4x usual sizeFiling
- 6 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedDec 3, 2018 +14 days
Sold 68 shares at $4.05 ($275)
Domzalski David, CEO
Sold 0% of holdings ($593k position)146,409 shares left0.1x usual sizeFiling
- 7 Form 4 sale Foamix Pharmaceuticals Ltd.UnusualApr 1, 2019 +119 days
Sold 5,096 shares at $3.75 ($19k)
Domzalski David, CEO
Sold 2.3% of holdings ($824k position)214,595 shares left8.5x usual sizeFiling
- 8 Form 4 sale Foamix Pharmaceuticals Ltd.UnusualJul 1, 2019 +91 days
Sold 3,355 shares at $2.35 ($8k)
Domzalski David, CEO
Sold 1.6% of holdings ($504k position)211,240 shares left5.6x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2019 | Jul 3, 2019 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 3,355 | $8k | 1.6% | Unusual | SEC |
| Apr 1, 2019 | Apr 3, 2019 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 5,096 | $19k | 2.3% | Unusual | SEC |
| Dec 3, 2018 | Dec 6, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 68 | $275 | 0.0% | Plan not stated | SEC |
| Nov 19, 2018 | Nov 20, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 5,036 | $20k | 3.3% | Unusual | SEC |
| Nov 8, 2018 | Nov 13, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 2,062 | $9k | 1.3% | Unusual | SEC |
| Oct 1, 2018 | Oct 2, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 601 | $3k | 0.4% | Plan not stated | SEC |
| Sep 4, 2018 | Sep 6, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 67 | $380 | 0.0% | Plan not stated | SEC |
| Aug 8, 2018 | Aug 9, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 8,238 | $47k | 5.1% | Unusual | SEC |
| Jul 2, 2018 | Jul 3, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 602 | $3k | 0.4% | Unusual | SEC |
| Jun 1, 2018 | Jun 4, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 67 | $352 | 0.0% | Plan not stated | SEC |
| Apr 2, 2018 | Apr 4, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 602 | $3k | 0.4% | Plan not stated | SEC |
| Mar 1, 2018 | Mar 5, 2018 | Foamix Pharmaceuticals Ltd. | CEO | Form 4 sale | 66 | $393 | 0.0% | Plan not stated | SEC |